Total Funding
35
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1944335
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer.
Acquired by 
Amgen
Tom Launder: Senior Manager, Clinical Data ManagementPast Role: BioPrecision, CEO- N. Anthony Coles: President, Chief Executive Officer and Member of the Board
Amgen
About the Company
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.
